Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $279M; returns 1 day +0.0%, 1 week +0.8%, 1 year -58.9%.

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oral small molecule therapeutics designed to modulate gene expression, addressing the root causes of genetically defined rare diseases. The company utilizes a proprietary target discovery platform to identify epigenetic targets.

Groups FULC belongs to

• Biotechnology
• Clinical Stage Biotech
• Sickle Cell Disease
• Rare Diseases
• Hematology
• Biopharmaceutical
• Epigenetics
• Healthcare
• Clinical Stage
• Drug Discovery

FULC financial model: income statement, cash flow and balance sheet